ARCHIVES

Two Phase II Studies of Ibrutinib Deliver High Response Rates

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

R.S.K. Young Quits As FDA Oncology Group Leader

July 11, 1980

Obey Attacks NCI In Campaign Speech

October 29, 1976

Symposium to Focus on New Approaches to Drug Resistance

May 11, 1990

DeVita Denies NCI Broke Faith With Communities On CHOP Awards, Says Total Of 30 “Not Absolute”

August 15, 1980

Klausner, Nathan Discuss Challenge of Cancer Research In the “Post-Genome World”

January 15, 1999

Activists To Seek $660 Million For Breast Cancer Research, Legislation To Declare An “Epidemic”

February 12, 1993